Cargando…
Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Ephrin A4 (EFNA4) acts as an oncogene in multiple cancers but is little known in HCC. It is revealed that EFNA4 is highly expressed in patients with HCC and influences the proliferation of HCC cells; however, detailed regulatory...
Autores principales: | Yuan, Weidong, Zhao, Hewei, Zhou, Ang, Wang, Shaochuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683066/ https://www.ncbi.nlm.nih.gov/pubmed/36404439 http://dx.doi.org/10.1080/15384047.2022.2149039 |
Ejemplares similares
-
Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development
por: Schwab, Kristopher R, et al.
Publicado: (2007) -
Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma
por: Zhang, Yongqiang, et al.
Publicado: (2021) -
Pygo2 opens chromatin and cycles cells
por: Williams, Ruth
Publicado: (2009) -
Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells
por: Li, Jing, et al.
Publicado: (2017) -
EFNA1 in gastrointestinal cancer: Expression, regulation and clinical significance
por: Chu, Ling-Yu, et al.
Publicado: (2022)